Notably, the simultaneous over-expression of ID1, ID3 and IGJ genes was found as an independent prognostic feature that identifies B-ALL patients with poor EFS (p = 0.001, Fig. 1b) and OS (p = 0.001, Fig. 1c). This evidence concerns the gene ID3 and precursor B-cell acute lymphoblastic leukemia.